Have a personal or library account? Click to login
Studying the formation of aggregates in recombinant human granulocyte-colony stimulating factor (rHuG-CSF), lenograstim, using size-exclusion chromatography and SDS-PAGE Cover

Studying the formation of aggregates in recombinant human granulocyte-colony stimulating factor (rHuG-CSF), lenograstim, using size-exclusion chromatography and SDS-PAGE

Open Access
|May 2008

References

  1. A. K. Pavlou and J. M. Reichert, Recombinant protein therapeutics - success rates, market trends and values to 2010, Nature Biotechnol. 22 (2004) 1513-1519; DOI: 10.1038/nbt1204-1513.10.1038/nbt1204-1513
  2. A. C. Herman, T. C. Boone and S. Lu, Characterization, Formulation and Stability of Neupogen (Filgrastim), a Recombinant Human Granulocyte-colony Stimulating Factor, in Formulation, Characterization and Stability of Protein Drugs (Eds. R. Pearlman and Y. J. Wang), Plenum Press, New York 1996, pp. 303-328.10.1007/0-306-47452-2_7
  3. V. Gervais, A. Zerial and H. Oschkinat, NMR investigations of the role of the sugar moiety in glycosylated recombinant human G-CSF, Eur. J. Biochem. 247 (1997) 386-395.10.1111/j.1432-1033.1997.00386.x
  4. C. Wang, M. Eufemi, C. Turano and A. Giartosio, Influence of the carbohydrate moiety on the stability of glycoproteins, Biochemistry 35 (1996) 7299-7307; DOI: 10.1021/bi9517704.10.1021/bi9517704
  5. C. Nissen, Glycosylation of recombinant human granulocyte-colony stimulating factor: implications for stability and potency, Eur. J. Cancer 30A (Suppl. 3) (1994) S12-S14.
  6. M. Oheda, M. Hasegawa, K. Hattori, H. Kuboniwa, T. Kojima, T. Orita, K. Tomonou, T. Yamazaki and N. Ochi, O-linked sugar chain of hG-CSF protects it against polymerization and denaturation allowing it to retain its biological activity, J. Biol. Chem. 265 (1990) 11432-11436.10.1016/S0021-9258(19)38416-9
  7. A. Hüttmann, K. Schirsafi, S. Seeber and P. Bojko, Comparison of lenograstim and filgrastim: effects on blood cell recovery after high-dose chemotherapy and autologous peripheral blood stem cell transplantation, J. Cancer Res. Clin. Oncol. 131 (2005) 152-156; DOI: 10.1007/s00432-004-0636-x.10.1007/s00432-004-0636-x
  8. M. Hoglund, B. Smedmyr, M. Bengtsson, T. H. Totterman, U. Cour-Chabernaud and A. Yver, Mobilisation of CD34+ cells by glycosylated and non-glycosylated GSCF in healthy volunteers - A comparative study, Eur. J. Haematol. 59 (1997) 177-183.10.1111/j.1600-0609.1997.tb00972.x
  9. W. Wang, Instability, stabilization, and formulation of liquid protein pharmaceuticals, Int. J. Pharm. 185 (1999) 129-188; DOI: 10.1016/S0378-5173(99)00152-0.10.1016/S0378-5173(99)00152-0
  10. E. Y. Chi, S. Krishnan, B. S. Kendrick, B. S. Chang, J. F. Carpenter and T. W. Randolph, Roles of conformational stability and colloidal stability in the aggregation of rHuG-CSF, Protein Sci. 12 (2003) 903-913.10.1110/ps.0235703
  11. S. Krishnan, E. Y. Chi, J. N. Webb, B. S. Chang, D. Shan, M. Goldenberg, M. C. Manning, T. W. Randolph and J. F. Carpenter, Aggregation of G-CSF under physiological conditions: Characterization and thermodynamic inhibition, Biochemistry 41 (2002) 6422-6431; DOI: 10.1021/bi 012006m.
  12. M. W. Bruner, J. Goldstein, C. R. Middaugh, M. A. Brooks and D. B. Volkin, Size exclusion HPLC method for the determination of acidic fibroblast growth factor in viscous formulations, J. Pharm. Biomed. Anal. 15 (1997) 1929-1935; DOI: 10.1016/S0731-7085(96)02043-2.10.1016/S0731-7085(96)02043-2
  13. K. Ahrer, A. Buchacher, G. Iberer and A. Jungbauer, Detection of aggregate formation during production of human immunoglobulin G by means of light scattering, J. Chromatogr. A 1043 (2004) 41-46; DOI: 10.1016/j.chroma.2004.05.024.10.1016/j.chroma.2004.05.02415317411
  14. R. S. Gunturi, I. Ghobrial and B. Sharma, Development of a sensitive size exclusion HPLC method with fluorescence detection for the quantitation of rHuEPO aggregates, J. Pharm. Biomed. Anal. 43 (2007) 213-221; DOI: 10.1016/j.jpba.2006.06.006.10.1016/j.jpba.2006.06.00616875794
  15. J. P. Gabrielson, M. L. Brader, A. H. Pekar, K. B. Mathis, G. Winter, J. F. Carpenter and T. W. Randolph, Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation and sedimentation velocity, J. Pharm. Sci. 96 (2007) 268-279; DOI: 10.1002/jps.20760.10.1002/jps.2076017080424
  16. C. F. Codevilla, L. Brum, P. R. de Oliveira, C. Dolman, B. Rafferty and S. L. Dalmora, Validation of an SEC-HPLC method for the analysis of rhG-CSF in pharmaceutical formulation, J. Liq. Chrom. 27 (2004) 2689-2698; DOI: 10.1081/JLC-200029121.10.1081/JLC-200029121
  17. S. W. Raso, J. Abel, J. M. Barnes, K. M. Maloney, G. Pipes, M. J. Treuheit, J. King and D. N. Brems, Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state, Protein Sci. 14 (2005) 2246-2257; DOI: 10.1110/ps.051489405.10.1110/ps.051489405225347916131655
  18. U. K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685; DOI: 10.1038/227680a0.10.1038/227680a05432063
  19. M. E. Cromwell, E. Hilario and F. Jacobson, Protein aggregation and bioprocessing, AAPS Journal 8 (2006) E572-E579; DOI: 10.1208/aapsj080366.10.1208/aapsj080366276106417025275
DOI: https://doi.org/10.2478/v10007-008-0003-6 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 199 - 206
Published on: May 30, 2008
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2008 Jasmina Ribarska, Suzana Jolevska, Ana Panovska, Aneta Dimitrovska, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 58 (2008): Issue 2 (June 2008)